Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
60.58
+1.15 (1.94%)
Feb 5, 2025, 11:58 AM EST - Market open
Vericel Employees
Vericel had 314 employees as of December 31, 2023. The number of employees increased by 9 or 2.95% compared to the previous year.
Employees
314
Change (1Y)
9
Growth (1Y)
2.95%
Revenue / Employee
$722,433
Profits / Employee
$11,299
Market Cap
2.99B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
VCEL News
- 21 days ago - Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 21 days ago - Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets - GlobeNewsWire
- 6 weeks ago - Vericel Corporation: Hard To Justify Current Valuation - Seeking Alpha
- 3 months ago - Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 3 months ago - Vericel Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024 - GlobeNewsWire
- 5 months ago - Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024 - GlobeNewsWire
- 5 months ago - Vericel Announces FDA Approval and Commercial Availability of MACI Arthro - GlobeNewsWire